Arcus Biosciences
RCUS
Arcus Biosciences (RCUS) - P/B ratio
P/B ratio as of April 2024 : 3.06
According to Arcus Biosciences
's latest financial reports the company has a price-to-book ratio of 3.06.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Arcus Biosciences - P/B ratio (from 2018 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.09 | 35.78% |
| 2022-12-31 | 2.28 | -32.5% |
| 2021-12-31 | 3.38 | 0.63% |
| 2020-12-31 | 3.36 | 18.69% |
| 2019-12-31 | 2.83 | 38.73% |
| 2018-12-31 | 2.04 | |
| 2017-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.43 | -20.74% | 🇺🇸 USA |